1. Executive Summary: The Headline
- Mixed bag with a revenue beat but modest profit/margin miss. Consolidated revenue rose 19% YoY to ₹4,413 cr on 8% underlying volume growth; EBITDA grew ~12% to ₹820 cr; PAT increased 13.9% to ₹523 cr. EBITDA margin contracted ~50–120 bps YoY to 18.6%.Cnbctv18
- Overarching narrative: Broad-based volume-led growth across India, Indonesia, and Africa/USA/Middle East (GAUM), supported by pricing actions. International markets (especially GAUM) were strong drivers. Commodity inflation (palm oil, crude-linked inputs) pressured margins, though the company retained full-year guidance and declared a ₹5 interim dividend.
2. Actuals vs. Market Estimates (The Core Analysis)
Consolidated sales grew 19% (15% constant currency) with 8% UVG. Standalone India: 13% sales growth with 7% UVG (impacted by ~150 bps trade inventory correction). GAUM: +40% in INR / +23% constant currency with 16% UVG and strong EBITDA growth. Indonesia: +20% sales with 8% UVG. No major one-off exceptional items noted in the quarter. H1 tracking ahead of plan in revenue.Cnbctv18
3. Brokerage Stance & Target Revisions
Pre-result stance was mixed but generally constructive after the early-October business update (high-teens revenue, high-single-digit volumes, double-digit EBITDA expected). Nomura retained Buy with a target of ₹1,110. Other houses have ranged from Hold/Underperform (e.g., CLSA Underperform ~₹743, HSBC Hold ~₹990) to Buy (HDFC Securities ~₹1,250 earlier, JM Financial Buy ~₹1,250). Primary thesis centres on volume-led recovery, international momentum (Indonesia recovery + GAUM strength), and portfolio initiatives. Main concern is near-term margin pressure from elevated commodity costs. Targets are likely to see limited upgrades given the margin print.
4. Management Guidance & Commentary Analysis
Tone is confident and execution-oriented. Management reiterated FY27 guidance of high-single-digit underlying volume growth for the standalone (India) business and double-digit revenue + EBITDA growth at the consolidated level. Revenue is running ahead of plan in H1, with potential to exceed guidance in select areas. Demand is described as broad-based across India, Indonesia, and Africa. The company is addressing input-cost inflation through calibrated pricing, cost savings, and operational efficiencies while prioritising volume-led growth and brand investments. Guidance stacks up in line with or slightly ahead of street expectations on top-line/volume, with continued caution on margins.Businessworld
5. Probable Market Reaction & Trading Setup
Immediate sentiment: Mildly positive to range-bound. Shares closed ~1.8–2% higher at ₹837 on October 29 (results released after market hours). The early-October business update had already provided a positive signal, so the full results largely confirm expectations. Expect a modest positive open or flat-to-positive bias on the next session, with potential for profit-booking given the margin contraction and PAT miss versus some polls.
The “why”: A clear revenue and volume beat, strong international contribution (GAUM/Indonesia), retained guidance, and the interim dividend support the recovery narrative after prior weakness. However, YoY margin compression from commodity inflation and the modest profit miss versus street estimates act as a drag, limiting aggressive buying. The stock has underperformed for much of the year, so confirmation of H1 momentum is helpful but not transformative.
Key catalyst for traders: Commentary on the trajectory of commodity costs, pricing realisation, and margin recovery into H2, plus any colour on India volume trends post-inventory correction. Evidence of sustained double-digit EBITDA growth and easing input inflation would drive buying or short-covering; further caution on margins would invite selling pressure.
This is a reaction framework based on the reported numbers, poll comparisons, and same-day price action, not a recommendation.
Bramesh Bhandari
Technical Analyst, Trader, and Educator publishing daily market geometry, W.D. Gann levels, and financial astrology cycles since 2008. Creator of custom TradingView Pine Script scanners for Nifty, Bank Nifty, Gold, and Global Indices.
